MK-1775, soluble in DMSO and ethanol and insoluble in water, targets the Wee1 kinase, which regulates the G2/M checkpoint in the cell cycle, leading to increased sensitivity of cancer cells to DNA-damaging agents. It targets Wee1.
MK-1775 can be used to research Wee1 kinase inhibition in combination with DNA-damaging agents in cancer therapy.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.